Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compliance markers for pregabalin in opioid abusers
NCT02276989Phase 2Withdrawn
- Sponsor
- Georgetown University
- Start
- Dec 2014
- Primary completion
- Jan 2016
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of acetazolamide, quinine in chronic pain, opioid use disorder (OUD), sponsored by Georgetown University. Planned start Dec 2014; status: withdrawn.
02
Drugs
acetazolamidequinine
03
Conditions
chronic painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02276989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276989.